Use of Macrogol to Accelerate Feeding Advancement in Extremely Preterm Infants
Neonatology · 2025
DOI: 10.1159/000543050 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Neonatology, 2025. Verfasst von Kirstin Barbara Faust und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University Hospital of Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Enteral Nutrition, Infant, Extremely Premature, Polyethylene Glycols. Die Arbeit nennt 28 Literaturangaben.
Themen: Neonatologie
Abstract (Originalsprache)
Introduction
Delayed enteral nutrition is associated with a higher risk for adverse outcomes in extremely preterm infants. Limited evidence exists on therapeutic options to support meconium evacuation and increase gastrointestinal motility. The aim of this study was to determine the effect of macrogol on feeding tolerance and microbiome establishment in preterm infants 30% of their infants as compared to the remaining units, and the single-center Immunoregulation-of-the-Newborn (IRoN) study including gut microbiome assessment of infants born before and after implementation of macrogol use in this NICU.
Results
In the GNN study cohort including 4,290 infants, advancement to full enteral feedings was significantly faster in macrogol-using NICUs compared to the remaining NICUs (median/IQR: 14/12 vs. 16/14 days, p = 0.001). Risk for short-term outcomes such as sepsis or abdominal complications was not elevated in units with regular use of macrogol. In the IRoN cohort (n = 68), macrogol treated infants had a shorter time to reach full enteral feeding (median/IQR: macrogol 12/6, control 16/6 days, p = 0.004). Higher Bifidobacterium longum abundance in the gut microbiome correlated with acceleration to full enteral nutrition.
Conclusion
Our observational data suggests that early off-label use of macrogol may support feeding advancement in highly vulnerable babies. These data provide a basis for a randomized controlled trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University Hospital of Lübeck, Lübeck, Germany.
- German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Lübeck, Germany.
- German Neonatal Network (GNN), Lübeck, Germany.
- Department of Infectious Diseases and Microbiology, University of Lübeck, Lübeck, Germany.
- Institute for Nutriinformatics, Christian-Albrechts-University Kiel, Kiel, Germany.
- Department of Pediatrics, University Hospital Münster, Münster, Germany.
Zitieren
APA
Faust, K. B., Lupatsii, M., Römer, F., Graspeuntner, S., Waschina, S., Zimmermann, S., Humberg, A., Fortmann, M. I., Hanke, K., Böckenholt, K., Dirks, J., Silwedel, C., Rupp, J., Herting, E., Göpel, W., & Härtel, C. (2025). Use of Macrogol to Accelerate Feeding Advancement in Extremely Preterm Infants. Neonatology. https://doi.org/10.1159/000543050
Vancouver
Faust KB, Lupatsii M, Römer F, Graspeuntner S, Waschina S, Zimmermann S, et al. Use of Macrogol to Accelerate Feeding Advancement in Extremely Preterm Infants. Neonatology. 2025. doi:10.1159/000543050
BibTeX
@article{Faust2025,
author = {Faust, Kirstin Barbara and Lupatsii, Mariia and Römer, Frederike and Graspeuntner, Simon and Waschina, Silvio and Zimmermann, Sina and Humberg, Alexander and Fortmann, Mats Ingmar and Hanke, Kathrin and Böckenholt, Kai and Dirks, Johannes and Silwedel, Christine and Rupp, Jan and Herting, Egbert and Göpel, Wolfgang and Härtel, Christoph},
title = {Use of Macrogol to Accelerate Feeding Advancement in Extremely Preterm Infants},
journal = {Neonatology},
year = {2025},
doi = {10.1159/000543050}
}
EUVIMED